Rivastigmine for Alzheimer’s - Know How It Works

What Is Rivastigmine?

As awareness about brain diseases that affect memory and thinking increased, scientists began developing new medicines to treat these conditions.

Rivastigmine is a medication that was developed in 1985 and is commonly used to help manage memory and thinking problems in people with Alzheimer’s disease. It works by improving communication between brain nerve cells, which can help reduce symptoms related to cognitive decline. Although medicines like rivastigmine play an important role in the treatment of Alzheimer’s disease, their benefits are limited and do not cure the condition.

Medication alone is not sufficient to manage the disease effectively. Comprehensive care also includes supportive therapies, structured daily activities, and emotional support, all of which are essential for improving the overall quality of life of individuals living with Alzheimer’s disease.

Is Rivastigmine FDA Approved?

The Food and Drug Administration (FDA) approved Rivastigmine for medical use in 1997.

Drug Group:

Rivastigmine belongs to the cholinesterase inhibitor group of drugs. It acts by increasing the levels of acetylcholine in the brain, thereby improving communication between nerve cells.

Through this mechanism, it helps enhance memory and cognitive function in affected individuals. While it does not cure the underlying disease, it is used to slow the progression of cognitive decline and support daily functioning for a limited period.

Available Doses and Dosage Forms:

Capsule:

• 1.5 milligram (mg).

• 3 mg.

• 4.5 mg.

• 6 mg.

Transdermal Patch:

• 4.6 mg/24 hour (hr).

• 9.5 mg/24 hr.

• 13.3 mg/ 24 hr.

For Patients

How Does Rivastigmine Work?

• The brain uses a chemical called acetylcholine to send messages between nerve cells.

• This chemical is important for memory and learning.

• In Alzheimer’s disease, acetylcholine levels become very low.

• Rivastigmine prevents acetylcholine from breaking down.

• This increases the amount of acetylcholine in the brain.

• Better chemical levels help nerve cells communicate more effectively.

• This can temporarily improve memory and thinking or slow symptom worsening.

What Is the Dosage of Rivastigmine?

For Alzheimer's:

• A person can take it as a pill, starting with a low dose of 1.5 mg twice a day and slowly increasing it to a maximum of 6 mg twice a day for maintenance.

• There is also a patch a person can wear, starting with a 4.6 mg patch that they can change daily.

• A person can increase to a 9.5 mg patch after 4 weeks and up to a 13.3 mg patch if needed. This is typically used for moderate to severe Alzheimer's.

For Parkinson's Dementia:

• Similarly, a person can take it as a pill, starting with 1.5 mg twice a day and increasing to a maximum of 6 mg twice a day.

• Patches are an option, too, starting with a 4.6 mg patch, and the person may increase it to 9.5 mg after 4 weeks and up to 13.3 mg if necessary.

How Is Rivastigmine Taken?

Rivastigmine is a medication used for Alzheimer's disease, and it comes in different forms:

Capsules to Swallow or a Liquid Solution to Drink:

• The patient is asked to take it twice daily, during morning and evening meals.

• When the patient starts taking it, they usually begin with a smaller dose of 3 mg (milligrams) a day, split into two doses.

• Over time, this dose can be increased every couple of weeks to between six and twelve mg daily. Most of the dose taken in a day is 12 mg.

Patches:

• These patches stick to the skin and slowly release the medication.

• They come in different strengths: 4.6 mg, 9.5 mg, or thirteen mg daily. The patches tend to have fewer side effects compared to the capsules.

• They are a good option for people who have trouble swallowing pills, and caregivers often find them helpful.

• Only one patch should be worn at a time. It should be put on different areas of the skin each time to avoid skin irritation.

What Are the Things to Inform the Doctor Before Taking Rivastigmine?

Patients should inform their doctor if they have had:

• Asthma.

• Prostate enlargement.

• Ulcers.

• Heart rhythm issues.

• Seizures.

• Tremors.

• Heart or lung problems.

• Kidney or Liver troubles.

What Are the Therapeutic Uses of Rivastigmine?

• Rivastigmine helps improve memory and awareness.

• It makes daily activities easier for some patients.

• It improves brain chemical balance.

• Studies show patients may perform about 30 percent better on memory tests.

• It may reduce hallucinations and anxiety in some patients.

What Are the Side Effects of Taking Rivastigmine?

Most side effects are mild and improve with time.

• Nausea and vomiting.

• Loss of appetite.

• Diarrhea.

• Dizziness.

• Headache.

• Muscle cramps.

• Feeling tired.

• Sleep problems.

Dietary Considerations:

• Rivastigmine should be taken with food.

• It should be taken at the same time every day.

• Liquid doses should be measured with the provided syringe.

Missed Dose:

• Take the missed dose as soon as remembered.

• Skip the dose if the next dose is near.

• Never take two doses together.

• Contact the doctor if doses are missed for more than three days.

Overdose:

• Taking too much Rivastigmine can be dangerous.

• Symptoms include severe nausea, vomiting, sweating, weakness, and seizures.

• Severe overdose can cause breathing problems or collapse.

• Immediate medical help is required.

Managing Overdose:

• Overdose management approaches change over time, so it is best to contact a poison control center for the latest advice on any drug overdose.

• Rivastigmine has a short time in the bloodstream and moderately inhibits an enzyme for about eight to ten hours. If there is an overdose without symptoms, it is recommended to avoid taking more for the next twenty-four hours.

• If an overdose happens, general supportive care should be provided. Overdosing on drugs like Rivastigmine can lead to a cholinergic crisis with symptoms like severe nausea, vomiting, sweating, slow heart rate, low blood pressure, breathing problems, collapsing, and seizures. There might also be muscle weakness, potentially causing breathing issues and even death.

Storage:

Keep the medicine in a tightly closed container at room temperature. Store it away from heat, moisture, and direct sunlight. Do not allow it to freeze. Keep it out of reach of children. Dispose of any unused or expired medicine as instructed by your doctor or pharmacist.

For Doctors

Indications:

• Rivastigmine is used to help improve gait stability and lower the risk of falls.

• In geriatric patients with preexisting cognitive impairments, Rivastigmine can aid in reducing postoperative delirium after surgery.

• It also offers cognitive improvement for individuals with dementia with Lewy bodies.

• Rivastigmine administration is associated with around 30 percent enhanced memory performance in comparison to non-users.

• Rivastigmine users experience alleviated anxiety levels and decreased instances of hallucinations and delusional perceptions.

Dose:

Individual patient dosages may vary. Adhere to the physician's instructions or label directions. Do not alter the dosage unless directed by the physician. The dose is contingent on the medication's potency, dosing frequency, time intervals between doses, and treatment duration relative to the medical condition.

For Oral Administration (Capsules or Solution)

For Alzheimer's Treatment:

• Adults: Initiate at 1.5 milligrams (mg) administered twice daily. The physician may incrementally adjust the dose based on necessity and tolerance. Typically, the maximum dose does not exceed 6 mg twice daily.

• Children: Dosage is determined by the physician.

For Parkinson's Treatment:

• Adults: Commence with 1.5 milligrams (mg) taken twice daily. The physician may incrementally modify the dose based on necessity and tolerance. Usually, the maximum dose is 6 mg twice daily at most.

• Children: Dosage is determined by the doctor.

Pharmacodynamics:

Rivastigmine is a reversible cholinesterase inhibitor and belongs to the parasympathomimetic group of drugs. In Alzheimer’s disease, there is an early loss of cholinergic neurons in certain areas of the brain, leading to reduced levels of acetylcholine. This decrease is associated with problems in memory and thinking. Although the exact way rivastigmine works is not completely known, it is believed to improve cholinergic activity by slowing the breakdown of acetylcholine through reversible inhibition of cholinesterase. As a result, acetylcholine levels increase, which may help reduce symptoms. However, as the disease progresses and fewer cholinergic neurons are functional, the effectiveness of rivastigmine may diminish.

Mechanism of Action:

In the brain, there are two types of enzymes that break down a neurotransmitter called acetylcholine. These enzymes are like scissors that slice acetylcholine into smaller fragments.

• One enzyme called acetylcholinesterase (AChE), is seen at special spots where nerve cells communicate.

• The other enzyme, called butyrylcholinesterase (BuChE), is found in different parts of the brain where it helps control acetylcholine activity.

As people get older, the activity of these enzymes increases. In diseases like Alzheimer's, this activity goes even higher than normal. The drug Rivastigmine can stick to both of these enzymes and stop them from breaking down acetylcholine. This leads to increased concentration of acetylcholine, which can be helpful for the brain's communication.

Pharmacokinetics:

Rivastigmine is a medication used for Alzheimer's disease. About 40 percent of the dose is absorbed into the body when a person takes it. It behaves as expected at lower doses, but its effects become less predictable at higher doses. For example, doubling the dose from three mg to six mg leads to a threefold increase in the amount of the medication in the body. The time it takes for half of the medication to be eliminated from the body is about 1.5 hours, with most of the breakdown products being removed through the urine.

• Absorption: When a person takes Rivastigmine, the body absorbs it rapidly and completely, with the highest concentration in the blood reached within about an hour. Taking it with food delays this absorption by about ninety minutes, but it also increases the overall amount of the medication in the system.

• Distribution: Rivastigmine is widely distributed throughout the body, including crossing into the brain, affecting brain fluid concentrations. It is moderately bound to blood proteins and distributed equally between blood and plasma at different concentrations.

• Metabolism: The body processes Rivastigmine quickly, primarily through the kidneys. After the medication is broken down, the main component is excreted in the urine, making up about 40 percent of the total dose. This process is not significantly influenced by certain enzymes in the liver that usually play a role in drug metabolism. Importantly, Rivastigmine does not appear to have significant interactions with other drugs that are processed by a specific enzyme group called cytochrome P450.

Toxicity:

Toxic effects are expected to be similar to those seen with carbamate or organophosphate poisoning. These may include muscarinic symptoms such as excessive salivation, watery eyes, frequent urination, diarrhea, constricted pupils, increased airway secretions, and a slow heart rate. Nicotinic symptoms may also occur, including muscle weakness, muscle twitching, and, in severe cases, paralysis.

Contraindications of Rivastigmine

Rivastigmine should not be used in the following circumstances:

• Individuals with a documented history of hypersensitivity reactions to Rivastigmine or similar medications are contraindicated from its use.

• Caution is advised for patients with severe adverse reactions to analogous medications.

• A history of severe adverse reactions to specific medications should also warrant caution when considering Rivastigmine administration.

• Patients with a history of significant skin reactions to transdermal patches should use Rivastigmine cautiously.

• Patients with specific medical conditions should exercise prudence when initiating Rivastigmine therapy.

• Children under eighteen years of age should avoid Rivastigmine.

• Special caution is warranted for those with cardiovascular comorbidities, bradycardia, respiratory disorders, including asthma, peptic ulcers with bleeding, bleeding diathesis, or a history of seizures.

• Special consideration should be given to individuals with a body weight below 50 kg before prescribing Rivastigmine.

• Rivastigmine should be avoided in breastfeeding mothers.

Doctors must watch and evaluate before prescribing Rivastigmine to someone with these conditions.

Drug Interactions of Rivastigmine

• Interactions With Other Drugs:

  • Rivastigmine is broken down mainly by enzymes called esterases. Major cytochrome P450 enzymes that process other drugs do not significantly affect it.

  • There is no significant interaction between Rivastigmine and drugs like Digoxin, Warfarin, Diazepam, or Fluoxetine in healthy volunteers.

  • Rivastigmine's metabolism is not greatly influenced by commonly used medications.

• Use With Other Types of Medications:

  • Cholinesterase inhibitors like Rivastigmine could affect the activity of anticholinergic drugs.

  • Combining cholinesterase inhibitors with certain neuromuscular blockers or cholinergic agonists might have a combined effect.

• Carcinogenesis, Mutagenesis, and Fertility:

  • Rivastigmine did not cause cancer at doses up to 0.9 times the dose.

  • Sometimes, Rivastigmine caused chromosomal changes, but it was not genotoxic.

  • Rivastigmine is likely safe to use during pregnancy, but one should consult a physician before using it.

• Nursing and Pediatric Use:

  • Rivastigmine has not been proven to be passed into human breast milk; however, it and Rivastigmine are not recommended for nursing mothers.

  • Rivastigmine’s safety and effectiveness have not been properly tested in children for any condition.

Adverse Drug Effects of Rivastigmine

• Some side effects can appear when a person first starts taking Rivastigmine or when the dose is increased.

• The most common problems affect the stomach and digestion.

• People may feel nauseous or may vomit after taking the medicine.

• These stomach problems usually happen at the beginning of treatment or after a dose increase.

• Slowly increasing the dose and taking the medicine with food can help reduce these symptoms.

• Some people may experience difficulty with movement.

• Sleep problems can occur in a few patients.

• Muscle cramps may develop in some individuals.

• A general feeling of weakness may also be noticed.

Special Considerations:

• During Pregnancy: If the patient is pregnant and considering Rivastigmine, the doctor should be cautious. The medication should be avoided during pregnancy unless it is really necessary.

• While Breastfeeding: If the patient is breastfeeding, it is not recommended to use Rivastigmine. Based on the drug's properties, it could transfer to babies through breast milk.